A Phase Ib Study of PRJ1-3024 for Treatment of Advanced or Metastatic Melanoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Melanoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Cancer Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Jun Guo, Dr) · guoj307@126.com · 8610-88196348

Study leads

Hui Ouyang, Dr.
Study Director
VP

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

Pancreatic Cancer · Renal Cell Cancer · Breast Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Clinical Stage III Cutaneous Melanoma AJCC v8 · Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage IV Cutaneous Melanoma AJCC v8

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Little Rock, United States

Tebentafusp-tebn With LDT in Metastatic UM

Metastatic Uveal Melanoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Philadelphia, United States

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Colorectal Carcinoma · Endometrial Carcinoma · Melanoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Birmingham, United States · Los Angeles, United States